Stocks · Health care · Surgical & Medical Instruments & Apparatus

GLAUKOS Corp

GKOS Clue Score42
United States Fiscal year ends December CIK 0001192448 Results filed 28 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Tomas Navratil
28 Aug 2026
Chief Development Officer
Sell
10
$182.50
$1.83K
Tomas Navratil
28 Aug 2026
Chief Development Officer
Sell
6,091
$181.19
$1.10M
Tomas Navratil
28 Aug 2026
Chief Development Officer
Sell
7,643
$180.25
$1.38M
Leana Wen
31 Jul 2026
Director
Sell
525
$167.63
$88.01K
Leana Wen
1 May 2026
Director
Sell
1,700
$143.35
$243.70K
Joseph E Gilliam
1 May 2026
President & COO
Sell
19,573
$143.54
$2.81M
Tomas Navratil
16 Mar 2026
Chief Development Officer
Sell
272
$99.05
$26.94K
Tomas Navratil
16 Mar 2026
Chief Development Officer
Sell
299
$98.21
$29.36K
Tomas Navratil
16 Mar 2026
Chief Development Officer
Sell
460
$97.33
$44.77K
Joseph E Gilliam
18 Nov 2025
President & COO
Sell
19,340
$90.00
$1.74M

What was left out

Form 4 filings counted 81
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 24
Sales straight out of an exercise 32
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 1,342,035
History held since 30 Jun 2015